Amicus Therapeutics

BIO welcomes John Crowley as new CEO
Medriva
Tue, 12/5/23 - 10:00 am
BIO
John Crowley
Amicus Therapeutics
Amicus Therapeutics secures $430M from Blackstone in financing agreement
Medical Marketing and Media
Tue, 10/3/23 - 10:09 am
Amicus Therapeutics
Blackstone
funding
FDA approves Amicus Therapeutics' muscle disorder treatment
Reuters
Thu, 09/28/23 - 11:56 am
Amicus Therapeutics
FDA
Pompe disease
AT-GAA
FDA again delays review of Amicus rare disease drug
BioPharma Dive
Mon, 10/31/22 - 04:11 pm
Amicus Therapeutics
Pompe disease
China
FDA
AT-GAA
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
FDA
GSK
Amicus Therapeutics
AstraZeneca
Novartis
Supernus
JNJ
Ipsen
Y-mAbs Therapeutics
Go or no go? J&J’s bispecific FDA first
EP Vantage
Thu, 07/28/22 - 11:04 am
JNJ
Amicus Therapeutics
Acadia Pharma
Bluebird Bio
FDA
FDA hits Amicus with delay on 'breakthrough' Pompe drug
Endpoints
Wed, 05/11/22 - 10:34 am
Amicus Therapeutics
Pompe disease
earnings
AT-GAA
Crunch time for the SPAC space
EP Vantage
Sun, 02/27/22 - 10:18 pm
SPACs
Amicus Therapeutics
Valo Health
Khosla Ventures
Amicus exits gene therapy
EP Vantage
Fri, 02/25/22 - 09:32 am
Amicus Therapeutics
gene therapy
SPACs
spinoffs
Amicus' gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts
Fierce Biotech
Thu, 02/24/22 - 09:28 am
Amicus Therapeutics
gene therapy
SPACs
R&D
Amicus Splits into Two as FDA Sets PDUFA for Pompe Disease Treatment
BioSpace
Wed, 09/29/21 - 11:56 pm
Amicus Therapeutics
Pompe disease
Caritas Therapeutics
M&A
Amicus Puts Positive Spin on Failure of its Phase III Trial for Pompe Disease
BioSpace
Sat, 02/13/21 - 11:03 pm
Amicus Therapeutics
clinical trials
Pompe disease
AT-GAA
Amicus shares surge as Sanofi struggles to raise a cheer for mixed pivotal data for a PhIII contender — and analysts blow a raspberry
Endpoints
Wed, 06/17/20 - 10:07 pm
Sanofi
Amicus Therapeutics
clinical trials
Pompe disease
Avalglucosidase alfa
Lumizyme
Amicus shares early look at Batten disease gene therapy
Fierce Biotech
Thu, 08/1/19 - 10:31 am
Amicus Therapeutics
Batten disease
gene therapy
AAV-CLN6
Thermo Fisher to manufacture gene therapies being developed by Amicus
Fierce Pharma
Mon, 07/1/19 - 07:38 pm
Thermofisher
Amicus Therapeutics
gene therapy
CDMOs
Amicus widens UPenn gene therapy collaboration
Biopharma Dive
Wed, 05/29/19 - 10:35 pm
Amicus Therapeutics
UPenn
gene therapy
Galafold
Fabry disease
Amicus Announces Positive Results for AT-GAA in Pompe Disease
Fri, 10/5/18 - 09:46 am
Amicus Therapeutics
AT-GAA
Pompe disease
Amicus Therapeutics Ramps Up Gene Therapy Portfolio with Acquisition of 10 Programs
CP Wire
Thu, 09/20/18 - 09:46 am
Amicus Therapeutics
gene therapy
Batten disease
FDA kills off Amicus’ 2018 accelerated approval plan
Fierce Biotech
Mon, 09/10/18 - 09:52 am
FDA
Amicus Therapeutics
Pompe disease
AT-GAA
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro

Pages